Back
T Rowe Price Ultra Short-Term Bond ETF Vs. Crinetics Pharmaceuticals Industry Stock Comparison
Sell
12
TBUX
T Rowe Price Ultra Short-Term Bond ETF
Last Price:
$49.64
Seasonality Move:
-0.16%
Sell
2
CRNX
Crinetics Pharmaceuticals
Last Price:
$40.59
Seasonality Move:
-6.74%
Sell
12
T Rowe Price Ultra Short-Term Bond ETF (TBUX)
is a Sell
Is T Rowe Price Ultra Short-Term Bond ETF a Buy, Sell or Hold?
-
The current T Rowe Price Ultra Short-Term Bond ETF [TBUX] share price is $49.66. The Score for TBUX is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
-
TBUX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
2
Crinetics Pharmaceuticals (CRNX)
is a Sell
Is Crinetics Pharmaceuticals a Buy, Sell or Hold?
-
The current Crinetics Pharmaceuticals [CRNX] share price is $40.59. The Score for CRNX is 2, which is 96% below its historic median score of 50, and infers higher risk than normal.
-
CRNX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
TBUX Stock Price Chart
What is T Rowe Price Ultra Short-Term Bond ETF's stock price today?
-
The T Rowe Price Ultra Short-Term Bond ETF share price today is $49.66Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TBUX is experiencing selling pressure, which indicates risk of future bearish movement.
CRNX Stock Price Chart
What is Crinetics Pharmaceuticals's stock price today?
-
The Crinetics Pharmaceuticals share price today is $40.59Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRNX is experiencing selling pressure, which indicates risk of future bearish movement.
TBUX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.03 | Sell |
Relative Strength Index (14 RSI): | 48.23 | Sell |
Chaikin Money Flow: | -105643 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (49.61 - 49.81) | Sell |
Bollinger Bands (100): | (49.68 - 49.86) | Sell |
CRNX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.44 | Sell |
Relative Strength Index (14 RSI): | 22.69 | Sell |
Chaikin Money Flow: | -2576687 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (49.5 - 57.26) | Sell |
Bollinger Bands (100): | (51.08 - 57.64) | Sell |
TBUX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 49.62 | Buy |
20-day SMA: | 49.7 | Sell |
50-day SMA: | 49.72 | Sell |
200-day SMA: | 49.63 | Buy |
8-day EMA: | 49.65 | Buy |
20-day EMA: | 49.68 | Sell |
50-day EMA: | 49.72 | Sell |
200-day EMA: | 49.61 | Buy |
CRNX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 49.44 | Sell |
20-day SMA: | 52.35 | Sell |
50-day SMA: | 55.3 | Sell |
200-day SMA: | 51.01 | Sell |
8-day EMA: | 48.54 | Sell |
20-day EMA: | 51.52 | Sell |
50-day EMA: | 53.69 | Sell |
200-day EMA: | 49.87 | Sell |
T Rowe Price Ultra Short-Term Bond ETF Earnings Growth & TBUX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Crinetics Pharmaceuticals Earnings Growth & CRNX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.47 per share.
T Rowe Price Ultra Short-Term Bond ETF Technical Analysis
Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Crinetics Pharmaceuticals Technical Analysis
Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |